Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Bexlosteride
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | LY 300502 |
Routes of administration |
Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C14H16ClNO |
Molar mass | 249.74 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Bexlosteride is a potent and noncompetitive inhibitor of the enzyme 5α-reductase related to finasteride and dutasteride. It is selective for the type I isoform of the enzyme. It advanced to Phase III clinical trials, but development was halted at that stage, and it was never marketed.
See also
Drugs used in benign prostatic hyperplasia (G04C)
| |
---|---|
5α-Reductase inhibitors | |
Alpha-1 blockers | |
Steroidal antiandrogens | |
Herbal products | |
Others |